ADAPTIVE BIOTECHNOLOGIES CORPORATION Depreciation
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Depreciation of $6.69 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for the quarter ending 2026-06-30 was $3.27M, a 19.78% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for the quarter ending 2026-03-31 was $3.42M, a 20.73% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for the quarter ending 2025-12-31 was $3.77M, a 6.32% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for the quarter ending 2025-09-30 was $3.98M, a 4.47% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for fiscal 2025 was $16.13M, a 8.08% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for fiscal 2024 was $17.55M, a 14.51% decline from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for fiscal 2023 was $20.53M, a 6.82% increase from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION depreciation for fiscal 2022 was $19.22M, a 56.85% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $6.69M 10-Q · filed 2026-08-04 | $10.46M derived: sum of 3 quarters · filed 2026-08-04 | $14.43M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $3.42M 10-Q · filed 2026-05-05 | $7.18M derived: sum of 2 quarters · filed 2026-05-05 | $11.16M derived: sum of 3 quarters · filed 2026-05-05 | $15.24M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $7.74M derived: sum of 2 quarters · filed 2026-02-26 | $11.82M derived: sum of 3 quarters · filed 2026-08-04 | $16.13M 10-K · filed 2026-02-26 |
| 2025-09-30 | $3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.06M derived: sum of 2 quarters · filed 2026-08-04 | $12.37M 10-Q · filed 2025-11-05 | $16.39M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $8.39M 10-Q · filed 2026-08-04 | $12.41M derived: sum of 3 quarters · filed 2026-08-04 | $16.57M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $4.31M 10-Q · filed 2026-05-05 | $8.33M derived: sum of 2 quarters · filed 2026-05-05 | $12.49M derived: sum of 3 quarters · filed 2026-05-05 | $17.07M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.18M derived: sum of 2 quarters · filed 2026-02-26 | $12.76M derived: sum of 3 quarters · filed 2026-02-26 | $17.55M 10-K · filed 2026-02-26 |
| 2024-09-30 | $4.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $8.74M derived: sum of 2 quarters · filed 2025-11-05 | $13.53M 10-Q · filed 2025-11-05 | $18.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $9.37M 10-Q · filed 2025-08-05 | $14.33M derived: sum of 3 quarters · filed 2026-02-26 | $19.67M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.79M 10-Q · filed 2025-05-01 | $9.75M derived: sum of 2 quarters · filed 2026-02-26 | $15.09M derived: sum of 3 quarters · filed 2026-02-26 | $20.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $10.30M derived: sum of 2 quarters · filed 2026-02-26 | $15.53M derived: sum of 3 quarters · filed 2026-02-26 | $20.53M 10-K · filed 2026-02-26 |
| 2023-09-30 | $5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $10.56M derived: sum of 2 quarters · filed 2024-11-07 | $15.57M 10-Q · filed 2024-11-07 | $20.43M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $5.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $10.23M 10-Q · filed 2024-08-01 | $15.09M derived: sum of 3 quarters · filed 2025-03-03 | $20.05M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $5.00M 10-Q · filed 2024-05-07 | $9.86M derived: sum of 2 quarters · filed 2025-03-03 | $14.82M derived: sum of 3 quarters · filed 2025-03-03 | $19.59M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $4.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $9.81M derived: sum of 2 quarters · filed 2025-03-03 | $14.58M derived: sum of 3 quarters · filed 2025-03-03 | $19.22M 10-K · filed 2025-03-03 |
| 2022-09-30 | $4.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $9.73M derived: sum of 2 quarters · filed 2023-11-09 | $14.36M 10-Q · filed 2023-11-09 | $18.78M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $4.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $9.41M 10-Q · filed 2023-08-02 | $13.83M derived: sum of 3 quarters · filed 2024-02-29 | $16.93M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $4.64M 10-Q · filed 2023-05-03 | $9.06M derived: sum of 2 quarters · filed 2024-02-29 | $12.16M derived: sum of 3 quarters · filed 2024-02-29 | $14.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.52M derived: sum of 2 quarters · filed 2024-02-29 | $10.00M derived: sum of 3 quarters · filed 2024-02-29 | $12.25M 10-K · filed 2024-02-29 |
| 2021-09-30 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.58M derived: sum of 2 quarters · filed 2022-11-03 | $7.83M 10-Q · filed 2022-11-03 | $9.76M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $2.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $4.73M 10-Q · filed 2022-08-03 | $6.66M derived: sum of 3 quarters · filed 2023-02-14 | $8.37M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $2.25M 10-Q · filed 2022-05-04 | $4.18M derived: sum of 2 quarters · filed 2023-02-14 | $5.89M derived: sum of 3 quarters · filed 2023-02-14 | $7.47M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $3.64M derived: sum of 2 quarters · filed 2023-02-14 | $5.21M derived: sum of 3 quarters · filed 2023-02-14 | $6.77M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $3.29M derived: sum of 2 quarters · filed 2021-11-03 | $4.84M 10-Q · filed 2021-11-03 | $6.49M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $3.13M 10-Q · filed 2021-08-04 | $4.78M derived: sum of 3 quarters · filed 2022-02-15 | $6.41M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $1.55M 10-Q · filed 2021-05-05 | $3.20M derived: sum of 2 quarters · filed 2022-02-15 | $4.84M derived: sum of 3 quarters · filed 2022-02-15 | $6.28M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $3.28M derived: sum of 2 quarters · filed 2022-02-15 | $4.73M derived: sum of 3 quarters · filed 2022-02-15 | $6.09M 10-K · filed 2022-02-15 |
| 2019-09-30 | $1.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $3.08M derived: sum of 2 quarters · filed 2020-11-10 | $4.45M 10-Q · filed 2020-11-10 | $5.61M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $2.81M 10-Q · filed 2020-08-10 | $3.98M derived: sum of 3 quarters · filed 2021-02-24 | $5.01M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $1.36M 10-Q · filed 2020-05-12 | $2.53M derived: sum of 2 quarters · filed 2021-02-24 | $3.57M derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $2.20M derived: sum of 2 quarters · filed 2021-02-24 | $4.30M 10-K · filed 2021-02-24 | |
| 2018-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.14M 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $2.10M 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $4.10M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |